Live Breaking News & Updates on Wenming chen

Stay informed with the latest breaking news from Wenming chen on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Wenming chen and stay connected to the pulse of your community

CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA

SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell th...

China , Beijing , Shanghai , United-states , France , Chinese , America , American , Wenming-chen , Zonghai-li , Chengcheng-fu , American-society-of-clinical-oncology

Police: Glen Burnie spa one of growing number of businesses being investigated in county

A Glen Burnie spa in which two people were arrested on prostitution charges late last week is part of a growing number of such businesses in the county, an Anne Arundel police spokesman said on Tuesday.

Annapolis , Maryland , United-states , Holy-trinity-catholic-church , Anne-arundel-county , Wenming-chen , Qiu-rong-zhang , A-glen-burnie , Dan-dickey , Glen-burnie , Jun-zhu , Fran-schmidt

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Australia , Shanghai , China , Hong-kong , Singapore , Beijing , Sadal , Kyongsang-bukto , South-korea , Chinese , Wenming-chen , Weili-zhao

CARsgen Presents Updated Research Results on BCMA CAR T-cell Product (CT053) at 2021 ASH Annual Meeting

/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...

China , Shanghai , United-states , Chinese , America , American , Wenming-chen , Zonghai-li , Chengcheng-fu , American-society-of-hematology , International-myeloma-working-group , Carsgen-therapeutics-holdings

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines
News provided by
Share this article
Share this article
SHANGHAI and HONG KONG, May 5, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the Chinese Society of Clinical Oncology (CSCO), the most prominent organization in oncology in China,
added multiple selinexor regimens to its 2021 Diagnosis and Treatment Guidelines (CSCO Guidelines) for treatment of multiple myeloma and lymphoma. Three selinexor regimens recommended by the Guideline for the Diagnosis and Treatment of myeloma include: (i) selinexor plus dexamethasone; and (ii) selinexor plus dexamethasone plus bortezomib; and (iii) selinexor plus dexamethasone plus pomalidomide for the treatment of relapsed myeloma.

Sadal , Kyongsang-bukto , South-korea , Australia , New-zealand , Hong-kong , Israel , Singapore , Beijing , China , Israeli , Chinese